Navigation Links
TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members
Date:5/9/2011

PLEASANTON, Calif., May 9, 2011 /PRNewswire/ -- TriReme Medical, Inc. (TriReme), a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the appointment of Mr. Supratim Bose and Mr. Michael Kleine to their Board of Directors.

Mr. Bose, Founder and CEO of Bose Consulting Group, is based in Singapore and was until recently Company Group Chairman at Johnson & Johnson with responsibilities for all of the Medical Devices & Diagnostics franchises across the Asia-Pacific Region.  Mr. Bose was also a member of the Worldwide Group Operating Committee at Johnson & Johnson Medical Devices & Diagnostics Group.

Mr. Kleine was previously President and CEO of Biosensors International (SGX), a medical device company listed on the Singapore Stock Exchange.  He brings vast experience in medical devices having held CEO and President positions at Microvention, Thermo Cardiosystems, Sorin Biomedical and Bird Medical.

"TriReme is developing an exciting range of innovative and differentiated devices and I am excited to help lead their Asian centered strategy," commented Mr. Bose.  Mr. Kleine added, "TriReme has created a truly global vision and its expansion is supported by a strong pipeline of unique products."

"Supratim and Mike's enormous experience with the Asian markets provide an extended dimension to both our Board and management teams.  TriReme is honored to have the endorsement of both industry veterans who support and share our global vision of medtech growth and development in Asia," said Eitan Konstantino, PhD, President and Chief Executive Officer of TriReme.

About TriReme Medical, Inc.

Based in Pleasanton, California, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The Company's novel balloon and stent therapies are specifically designed for large, unmet clinical needs.


'/>"/>
SOURCE TriReme Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Medical Announces Japanese Alliance
2. TriReme Medical Announces $17 Million Series D Financing
3. TriReme Medical, Inc. Receives FDA 510K Clearance for Glider(TM) PTA Balloon Catheter
4. TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
5. Frantz Medical Group Announces the Promotion of Stephanie Harrington to Chief Operating Officer
6. Major Medical Diagnostics Manufacturer Signs Agreement to Use AmbiCom Wireless Solution in Its Urinalysis Product Line
7. Samsung Medison Pledges to Become a World-Class Medical Device Company
8. Varian Medical Systems Spotlights Fully Integrated Intensity Modulated Proton Therapy at PTCOG 2011 Meeting
9. Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
10. China Medical Technologies to Present at Jefferies 2011 Global Healthcare Conference on June 7, 2011
11. Winner Medical Group Inc. to Host Second Quarter 2011 Earning Conference Call on Wednesday, May 11, 2011 at 08:30 a.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Cut Pro X users can now reveal the media of their split screens ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):